Following the market opening Thursday, the Dow traded up 0.17% to 25490.00 while the NASDAQ fell 0.14% to 9894.89. The S&P also rose, gaining 0.01% to 3050.43.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 2,381,360 cases with around 121,970 deaths. Brazil confirmed a total of over 1,188,630 COVID-19 cases with 53,830 deaths, while Russia reported a total of at least 613,140 confirmed cases and 8,590 deaths. In total, there were at least 9,440,530 cases of COVID-19 worldwide with over 483,200 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Energy shares climbed 1.8% on Thursday. Meanwhile, top gainers in the sector included Chesapeake Energy Corporation CHK, up 22%, and PrimeEnergy Resources Corporation PNRG, up 7%.
In trading on Thursday, utilities shares fell 1.4%.
Top Headline
Accenture Plc ACN reported better-than-expected results for its third quarter.
Accenture posted Q3 earnings of $1.90 per share, beating analysts’ estimates of $1.85 per share. The company reported quarterly sales of $10.99 billion, surpassing expectations of $10.88 billion.
Equities Trading UP
Ekso Bionics Holdings, Inc. EKSO shares shot up 91% to $5.92 after the company received FDA clearance to market its EksoNR robotic exoskeleton.
Shares of Aptevo Therapeutics Inc. APVO got a boost, shooting 55% to $8.91 as the company said it will receive seven year quarterly royalty payment stream from Pfizer for sales of Rituximab Biosimilar.
Vaxart, Inc. VXRT shares were also up, gaining 41% to $4.511 after the company signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP.
Equities Trading DOWN
Xeris Pharmaceuticals, Inc. XERS shares tumbled 34% to $3.505 after the company said it has commenced concurrent underwritten public offerings of $20 million in shares of its common stockand $60 million in aggregate principal amount of convertible senior notes due 2025.
Shares of Kaleyra, Inc. KLR were down 23% to $4.02 after the company reported pricing of public offering of common stock.
Magenta Therapeutics, Inc. MGTA was down, falling 19% to $7.86. Magenta Therapeutics priced its 7.5 million share public offering of common stock at $8 per share.
Commodities
In commodity news, oil traded down 1.7% to $37.36, while gold traded down 0.3% to $1,770.50.
Silver traded down 0.4% Thursday to $17.60, while copper fell 0.4% to $2.6405.
Euro zone
European shares were mixed today. The eurozone’s STOXX 600 rose 0.2%, the Spanish Ibex Index rose 0.1%, while Italy’s FTSE MIB Index declined 0.3%. Meanwhile, the German DAX 30 gained 0.3%, French CAC 40 gained 0.4% and UK shares fell 0.2%.
Economics
US durable goods orders climbed 15.8% in May, versus a revised 18.1% decline in April.
The US economy shrank by an annualized rate of 5% during the first quarter.
The US goods deficit increased to $74.34 billion in May versus $70.73 billion in the earlier month. Exports dipped 34.9%, while imports declined 22.9% for May.
US initial jobless claims rose 1.48 million for the latest week, versus analysts’ estimates for a reading of 1.30 million.
Corporate profits in the US dropped 12.4% to $1,672.3 billion in the first quarter.
US wholesale inventories fell 1.2% in May versus a revised 0.2% rise in April.
The Energy Information Administration’s weekly report on natural gas stocks in underground storage is scheduled for release at 10:30 a.m. ET.
The Kansas City Fed manufacturing index for June is scheduled for release at 11:00 a.m. ET. The index is expected to rise to -9 in June from a reading of -19 in May.
Federal Reserve Bank of Atlanta President Raphael Bostic will speak at 11:00 a.m. ET.
The Treasury is set to auction 4-and 8-week bills at 11:30 a.m. ET.
Federal Reserve Bank of Cleveland President Loretta Mester is set to speak at 12:00 p.m. ET.
The Treasury will auction 7-year notes at 1:00 p.m. ET.
Data on money supply for the recent week will be released at 4:30 p.m. ET.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
